| Group |
Operativemeasure |
Totalduration* |
Subjects(n) |
| |
|
each administration 30 min |
|
| VII |
4 × 0.5 mg/kg NaCl**
(control group) |
>2 h |
6 |
| VIII |
4 × 0.5 mg/kg BW MagnaDrugMitoxantrone** in a magnetic field |
>2 h |
6 |
| IX |
6 × 0.5 mg/kg BW MagnaDrugMitoxantrone** in a magnetic field |
>3 h |
6 |
| X |
8 × 0.5 mg/kg BW MagnaDrugMitoxantrone**in a magnetic field |
>4 h |
6 |
| Total number |
|
|
24 |
